Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

STEAM Teacher Scott Johnson and student Jackson Farmer with new prosthetic hand 3D-printed at Red Cross Elementary School – Photo by Fiona Morgan / Kentucky Department of Education Simply using ...

The publication says the time is right to pour all of its resources into its online news operation and get its journalism “in front of the most people.” By Katie Robertson Reporting from Atlanta When ...

Imagine if you could "print" a tiny skyscraper using DNA instead of steel. That’s what researchers at Columbia and Brookhaven are doing—constructing intricate 3D nanostructures by harnessing the ...

It feels like summer is really in full swing, evidenced by our first punishing heat wave of the season. With that behind us and some more moderate temperatures in the forecast ahead, today we’re ...

(KRON) — Last month, a woman was caught on camera yelling a racial slur toward two Black men in the Sonoma County city of Healdsburg. The video has been viewed by millions of people in a now-viral ...

Imagine that doctors could precisely print miniature capsules capable of delivering cells needed for tissue repair exactly where they are needed inside a beating heart. A team of scientists led by ...

Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.39 per share a year ago. These ...

When Laurie Dale started her role as Senior Leader of Assistive Technology Solutions at Ability Beyond, she knew she had to get creative when it came to providing technological assistance to young ...

Donors calling themselves "Hitler's Friend" and "I hate blacks" are among those who have helped a woman at the center of a racist viral video in Rochester this past week raise more than $600,000 to ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...